Navigation Links
Life Spine Adds New Lynx(TM) Cross Connector to Its Lumbar Fixation Offering
Date:3/10/2008

-- Innovative design allows snap-on rod attachment and self-alignment

capabilities

HOFFMAN ESTATES, Ill., March 10 /PRNewswire/ -- Life Spine announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to Lynx(TM), a new cross connector system designed for use in surgical lumbar fusion procedures.

Life Spine's President, CEO and founder Michael S. Butler indicated that Lynx' unique new design will allow a surgeon more options when performing lumbar spine surgery and presented with a need for a stabilizing cross connector system. "The Lynx represents another great product development accomplishment for Life Spine. The cross connector provides multiaxial adjustability in all planes and is simple to use, as it snaps onto the rods, self-adjusts and locks with a single instrument. What's more, we have developed both straight and pre-arched versions of the Lynx, providing more tissue sparing surgical options."

Lynx features a variety of lengths via its fenestrated design, with straight and arched versions available in an assortment of adjustable length configurations ranging from 25mm to 100mm. Lockup of the construct at both rods and at the cross connector's medial joint is accomplished with a single driver tool, which is designed to lock the implant at a predetermined force. The cross connector is designed from surgical grade titanium, making it exceptionally strong. Lynx has been designed to be extremely easy and intuitive to use, virtually eliminating the need for bending and requiring only minimal instrumentation.

About Life Spine

Life Spine is a full line spine company which develops and markets an innovative family of spinal implants and instruments to serve the orthopedic and neurosurgery communities. The company is dedicated to improving the quality of life for spinal patients worldwide by increasing procedural efficiency and efficacy through innov
'/>"/>

SOURCE Life Spine
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Syndicom to Launch Online Community for DePuy Spine
2. RSB Spine, LLC Announces FDA Clearance of New InterPlate(TM) Indications
3. Update: SpineMark Expands Management Team to Build Spine Care Network
4. ArthroCare Releases New SpineWand(R) for Less Invasive Spinal Surgeries
5. Tissue Genesis Signs Exclusive Distribution and License Agreement with SpineSmith
6. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
7. Surgery Best for Narrowing of Spine
8. Study finds spine surgery yields greater benefits over nonsurgical treatments
9. SpineMark, NeuStrategy Partner to Conduct Nations First Spine COE Survey(TM)
10. Neurologic & Orthopedic Hospital of Chicago Ranked Among Top in Nation for Spine Surgery
11. Breast cancer prevention practices vary across Canada
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 2Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 3Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 4Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 2Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 3Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 4Health News:Life Science And Medical Device Software Engineering Consulting Firm Full Spectrum Software Announces 12 New Contract Wins In 2009 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3
Other Medicine News:Health News:Lowering Blood Pressure Improves Brain Hemorrhage Outcomes 2Health News:Pacific Heart, Lung & Blood Institute Position on Ban Asbestos Legislation 2Health News:Pacific Heart, Lung & Blood Institute Position on Ban Asbestos Legislation 3Health News:Smart Balance Announces Sales Organization Appointments 2Health News:Smart Balance Announces Sales Organization Appointments 3Health News:Defending Champion Woody Austin Helps Memphis Kick-off Countdown to 2008 Stanford St. Jude Championship 2Health News:Defending Champion Woody Austin Helps Memphis Kick-off Countdown to 2008 Stanford St. Jude Championship 3Health News:Defending Champion Woody Austin Helps Memphis Kick-off Countdown to 2008 Stanford St. Jude Championship 4Health News:Defending Champion Woody Austin Helps Memphis Kick-off Countdown to 2008 Stanford St. Jude Championship 5Health News:Defending Champion Woody Austin Helps Memphis Kick-off Countdown to 2008 Stanford St. Jude Championship 6Health News:Gum Disease, HPV a Double Whammy 2Health News:Clinical trial volunteers mostly indifferent -- but not blind to -- researchers' financial conflicts 2Health News:Clinical trial volunteers mostly indifferent -- but not blind to -- researchers' financial conflicts 3
Breaking Medicine Technology:ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Mathematical modeling predicts response to Herceptin 52980 1Mathematical modeling predicts response to Herceptin 52980 2Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 1Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 2Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 3Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 4The CLASS Act 3A Retirement In Security 52977 1The CLASS Act 3A Retirement In Security 52977 2